Research milestones and news from ORGANOPlus.
ORGANOPlus Participates in 2026 SMART AGRITECH: GLOBAL NETWORKING DAY
ORGANOPlus joined the 2026 SMART AGRITECH: GLOBAL NETWORKING DAY to engage with investors and global partners on commercialization and international expansion. The event also highlighted the company’s growing…
AFPRO 2026: ORGANOPlus to Unveil VILLIORGAN™ for AI-Driven Livestock ESG Innovation
ORGANOPlus will participate in AFPRO 2026, held from July 15 to 17 at COEX in Seoul. The company will showcase VILLIORGAN™, an AI-powered animal biomimetic platform designed to…
CPHI South East Asia 2026: ORGANOPlus Showcases Proprietary Probiotic Strain OP820
ORGANOPlus presented Bifidobacterium adolescentis OP820 and its human gut-mimicking platform, VILLIORGAN™, at CPHI South East Asia 2026 in Bangkok. The company introduced its capabilities in probiotic strain discovery,…
ORGANOPlus Exhibits Human Validation Platform at BIO KOREA 2026
ORGANOPlus exhibited its human-relevant validation platform at BIO KOREA 2026.The company highlighted CANORGAN™ for tumor microenvironment-based immuno-oncology validation and VILLIORGAN™ for microbiome-related mechanism discovery.The platform supports preclinical decision-making…
AACR 2026 Highlights the Shift Toward Human-Relevant Platforms in Cancer Research
At AACR 2026, global attention focused on emerging technologies designed to reduce reliance on animal testing and improve the predictability of cancer research. Among them, ORGANOPlus presented its…
AACR 2026: ORGANOPlus Presents Preclinical Data on Microbiome-Derived Anticancer Candidate ‘OP820’
ORGANOPlus presented preclinical data on its microbiome-derived anticancer candidate ‘OP820’ at AACR 2026 in San Diego. The study demonstrated the anti-inflammatory and anticancer effects of Bifidobacterium adolescentis OP820,…
ORGANOPlus Participates in Inha University Hospital Open Lab “Connect Day” Networking Forum
ORGANOPlus was selected as a participating company in the Inha University Hospital Open Lab program and joined the 2026 “Connect Day” networking forum.The event brought together 26 innovative…
ORGANOPlus Showcases Oncology Validation Platform at BIO-Europe Spring 2026
ORGANOPlus presented its tumor microenvironment–based organ-on-a-chip platform at BIO-Europe Spring 2026, enabling human-relevant validation of oncology candidates.Partnering discussions confirmed growing demand for predictive, human-derived evaluation systems beyond traditional…
AACR 2026 Selects ORGANOPlus’ Microbiome Oncology Candidate OP820 for Poster Presentation
AACR 2026 selected OP820, a mucin-binding microbiome oncology candidate identified using ORGANOPlus’ villus-mimicking organ-on-a-chip platform, demonstrating translational efficacy across both in vitro and in vivo models.
